Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62264b065fb25cc787661238b64cd699 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-0209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-21001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-02 |
filingDate |
2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1c14292cb3b1b753d850fcbfd1c4f60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_349410ebf22a7fc27f4e621014c07ff5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e5e54729e6a3ac36ffde737e6b9b071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abcd5935047649dfbfd60dbbefd9249d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fe4ce183acfb903efac274a7181ce90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f39265ba63ed662eb6589da9e2f7517 |
publicationDate |
2017-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2017196945-A1 |
titleOfInvention |
Methods for treating and preventing neutrophil-derived net toxicity and thrombosis |
abstract |
Embodiments of the technology described herein are based upon the discoveries that neutrophil extracellular traps (NETs) provide a stimulus for thrombus formation and that NETs are present in stored blood products. Accordingly, some embodiments relate to methods of treating and preventing toxicity of NETs and thrombosis caused by NETs. Additional embodiments are directed towards methods of treating stored blood products to prevent transfusion-related injuries. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464833-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11578314-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020163264-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021401999-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11046942-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11046943-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11352613-B2 |
priorityDate |
2011-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |